SYSTEMIC AND INTRATHECAL IMMUNE ACTIVATION IN PERINATALLY HIV-INFECTED CHILDREN
ESPID eLearning, Charlotte Blokhuis, 179700
Treatment of MDR-TB
ESPID eLearning, H. Simon Schaaf, 179695
Kawasaki Disease
ESPID eLearning, Rolando Ulloa-Gutierrez, 179699
TB diagnostics for children
ESPID eLearning, Marc Tebruegge, 179694
When the immune system looses control- Dysregulation due to CTLA4 and LRBA deficiency
ESPID eLearning, David Sansom, 179698
In the search of a new TB vaccine
ESPID eLearning, Carlos Martin, 179693
Monogenic causes of immune dysregulation
ESPID eLearning, Juantxo Aróstegui, 179697
THE CLINICAL SYNDROMES AND OUTCOMES ASSOCIATED WITH INVASIVE GROUP A STREPTOCOCCAL (IGAS) INFECTIONS IN BRISTOL FROM 2006-2015.
ESPID eLearning, Natasha Daoud, 179687
APPLICATION OF A 2-TRANSCRIPT RNA SIGNATURE TO DISCRIMINATE BACTERIAL FROM VIRAL INFECTION IN YOUNG INFANTS USING DIVERSE RNA QUANTITATION PLATFORMS
ESPID eLearning, Jethro Herberg, 179691
MULTI-CENTER STUDY EVALUATING INCIDENCE, PREDISPOSING FACTORS AND CLINICAL CHARACTERISTICS OF PEDIATRIC INVASIVE GROUP A STREPTOCOCCAL DISEASE IN MADRID, SPAIN
ESPID eLearning, Lucia Marcela Figueroa Ospina, 179686
A NOVEL HOST-PROTEIN SIGNATURE OUTPERFORMS STANDARD LABORATORY PARAMETERS IN DIFFERENTIAL DIAGNOSIS OF ACUTE INFECTION ETIOLOGY OF FEBRILE CHILDREN
ESPID eLearning, Isaac Srugo, 179690
Will we have the first GAS vaccine at the horizon 2020?
ESPID eLearning, Andrew Steer, 179685
GWAS in children
ESPID eLearning, Mike Levin, 179689
Epidemiology: GAS disease in Europe and in the world in 10 questions
ESPID eLearning, Pierre Smeesters, 179683
Transcriptomics: Clinical applications in Infectious Diseases
ESPID eLearning, Octavio Ramilo, 179688
Paediatric HIV: The European Contribution
ESPID eLearning, Carlo Giaquinto, 179682
RSV disease severity: Insights into protective host immune responses
ESPID eLearning, Santtu Heinonen, 179681
ESPID Young Investigator Award 2017 Ceremony: Cerebral Malaria - Clotting and broken barriers in the brain
ESPID eLearning, Christopher Moxon, 179679
ESPID Young Investigator Award 2017 Ceremony: B Cell responses and beyond - Johannes Trück
ESPID eLearning, Pierre Smeesters, 179676
ESPID Education and Communication Award Ceremony
ESPID eLearning, Shai Ashkenazi, 179670
A MULTIPLE ANTIGEN PRESENTING SYSTEM (MAPS) VACCINE AGAINST MYCOBACTERIUM TUBERCULOSIS PULMONARY INFECTION
ESPID eLearning, Rick Malley, 179669
THE IMPACT OF AGE AT VACCINATION ON INFANT VACCINE RESPONSES: AN ANALYSIS OF IMMUNITY IN 7630 CHILDREN
ESPID eLearning, Merryn Voysey, 179668
Systems vaccinology
ESPID eLearning, Rafick-Pierre Sekaly, 179667
Reverse vaccinology
ESPID eLearning, Rino Rappuoli, 179666
Why infections in different places need different vaccine programmes
ESPID eLearning, B. Gessner, 179665
PHARMACOKINETICS, SAFETY AND EFFICACY OF OMBITASVIR/PARITAPREVIR/RITONAVIR ± DASABUVIR ± RIBAVIRIN IN HEPATITIS C GENOTYPE 1 OR 4 VIRUS INFECTED ADOLESCENTS: THE ZIRCON STUDY
ESPID eLearning, Stefan Wirth, 179649
BUNDLE APPROACH TO REDUCE VENTILATOR ASSOCIATED PNEUMONIA IN NEONATES: A QUALITY IMPROVEMENT INITIATIVE IN AN OUTBORN NICU OF DELHI.
ESPID eLearning, mamta jajoo, 179659
MMR AND INFLUENZA VACCINATION COVERAGE AMONG MIGRANT CHILDREN IN FINLAND – A REGISTER-BASED STUDY
ESPID eLearning, Paula Tiittala, 179664
TRANSIENT TACHYPNEA OF THE NEWBORN IS ASSOCIATED WITH INCREASED RISK OF BRONCHIOLITIS IN INFANTS
ESPID eLearning, Otto Helve, 179653
LATENT TUBERCULOSIS INFECTION IN YOUNG REFUGEES AND ASYLUM SEEKING MIGRANTS; A MULTICENTRE CROSS-SECTIONAL STUDY
ESPID eLearning, Maya Mueller-Hermelink, 179663
IMMUNOGENICITY OF DIFFERENT DOSING SCHEDULES OF TRIVALENT INFLUENZA VACCINE IN HIV-INFECTED PREGNANT WOMEN: A RANDOMIZED CONTROLLED TRIAL
ESPID eLearning, Marta S.C. Nunes, 179652
FIRST OUTBREAK OF ENTEROVIRUS RELATED BRAINSTEM ENCEPHALITIS IN WESTERN EUROPE: CHARACTERIZATION, MANAGEMENT AND EVOLUTION OF THE PATIENTS
ESPID eLearning, Núria Worner Tomasa, 179647
IMMUNOLOGICAL RESPONSE TO TREATMENT IN HIV-INFECTED MIGRANT CHILDREN IN EUROPE AS COMPARED TO DOMESTIC-BORN COUNTERPARTS
ESPID eLearning, Malte Kohns, 179662
IMPACT OF A CARBAPENEM ANTIMICROBIAL STEWARDSHIP PROGRAMME ON PATIENT OUTCOMES IN A WOMEN’S AND CHILDREN’S HOSPITAL
ESPID eLearning, Xue Fen Valerie Seah, 179656
New respiratory viruses
ESPID eLearning, Adam Meijer, 179646
Vaccination programmes in refugee camps
ESPID eLearning, Markus Hufnagel, 179661
Treatment of MDR enterobacteria
ESPID eLearning, Jesús Rodríguez-Baño, 179655
Enterovirus/parechovirus
ESPID eLearning, Heli Harvala, 179645
Immunisation during pregnancy
ESPID eLearning, Flor Muñoz, 179650
Antimicrobial stewardship in children
ESPID eLearning, Theoklis Zaoutis, 179654
Antibiotic-resistant pathogens in refugee children
ESPID eLearning, Daniel Glikman, 179660
MARKERS OF RISK TO DEVELOP A SEVERE INFECTION IN CHILDREN WITH FEVER AND NEUTROPENIA RELATED TO CHEMOTHERAPY
ESPID eLearning, Jesus Saavedra-Lozano, 179638
ANTIBODY ADMINISTRATION EFFECTIVELY TREATS PERTUSSIS IN A BABOON DISEASE MODEL AND PROVIDES FIVE WEEKS OF PERTUSSIS PROPHYLAXIS IN NEWBORN BABOONS
ESPID eLearning, Jennifer Maynard, 179644
EARLY TREATMENT OF CHAGAS DISEASE PREVENTS CONGENITAL TRANSMISSION.
ESPID eLearning, Jaime Altcheh, 184348
VIRAL KINETICS AND TREATMENT OF CYTOMEGALOVIRUS INFECTIONS IN IMMUNOCOMPROMISED CHILDREN
ESPID eLearning, Ben Margetts, 179637
NEGATIVE CYTOMEGALOVIRUS PCR IN NEONATAL DRIED BLOOD SPOTS: CAN WE RULE CONGENITAL INFECTION OUT? A STUDY FROM THE SPANISH REGISTRY (REDICCMV)
ESPID eLearning, Isabel Vives-Oñós, 179627
MOLECULAR BACTERIOLOGICAL SURVEILLANCE OF PAEDIATRIC ENTERIC FEVER IN NEPAL BETWEEN 2008 AND 2015
ESPID eLearning, Carl Britto, 179631
PERTUSSIS ANTIBODIES IN ENTIRE POPULATION, AMONG PATIENTS WITH PERTUSSIS AND THE TIME COURSE UP TO THREE YEARS AFTER THE DISEASE
ESPID eLearning, Piia Jõgi, 179642
CLINICAL AND MICROBIOLOGICAL CHARACTERIZATION OF INVASIVE VIRIDANS GROUP STREPTOCOCCI INFECTIONS IN CHILDREN WITH CANCER, FEVER AND NEUTROPENIA, SANTIAGO, CHILE, 2004-2015
ESPID eLearning, María Carolina Rivacoba Rojas, 179635
Immunsing pregnant women – success and challenges
ESPID eLearning, Gayatri Amirthalingam, 179641
Congenital CMV
ESPID eLearning, Tiziana Lazzarotto, 179626
Viral infection in the child with HSCT
ESPID eLearning, Janet Englund, 179634
The search for a better pertussis vaccine
ESPID eLearning, Camille Locht, 179640
Typhoid disease burden
ESPID eLearning, John Crump, 179629
Risk factors in the neutropenic child
ESPID eLearning, Maria Elena Santolaya, 179633
Global Pertussis Initiative
ESPID eLearning, Stanley Plotkin, 179639
Future treatments for early treated HIV-infected children
ESPID eLearning, Jintanat Ananworanich, 179623
Immunological characteristics in early treated HIV-infected children
ESPID eLearning, Nigel Klein, 179622
Multi-level microbial biology in the light of evolution
ESPID eLearning, Fernando Baquero, 179619
DESCRIPTION OF PREVALENCE OF SYMPTOMS RELATED ZIKA VIRUS IN PREGNANT WOMEN WITH CHILDREN WITH MICROCEPHALY DURING THE FIRST YEAR OF EPIDEMIC IN PERNAMBUCO/BRAZIL
ESPID eLearning, Luiza Mello, 179617
Zika
ESPID eLearning, Karin Nielsen, 179616
Dengue
ESPID eLearning, Elizabeth Barnett, 179615
Chinkungunya
ESPID eLearning, Marco Safadi, 179614
INCREASING VACCINE COVERAGE - BARRIERS AND ATTITUDES
ESPID eLearning, Robb Butler, 134427
GETTING VACCINATED - ACCESS AND ATTITUDES
ESPID eLearning, Irina Ljungqvist, 134426
VACCINE HESITANCY - THE EMERGENCE OF GLOBAL MISUNDERSTANDING
ESPID eLearning, Emilie Karafillakis, 134428
COMPARISON OF CHILDREN TESTING NEGATIVE AND POSITIVE FOR EBOLA VIRUS DISEASE IN EBOLA HOLDING UNITS, SIERRA LEONE
ESPID eLearning, Felicity Fitzgerald, 132227
RTSS MALARIA VACCINE., DOES IT WORK? IS IT SAFE?
ESPID eLearning, Brian Greenwood, 132228
TO LP OR NOT TO LP: SAFETY OF LUMBAR PUNCTURE IN COMATOSE CHILDREN WITH CLINCIAL FEATURES OF CEREBRAL MALARIA
ESPID eLearning, Christopher Moxon, 132229
REFUGEES ARRIVING IN EUROPE: THE MUNICH PAEDIATRIC INFECTION EXPERIENCE
ESPID eLearning, Ulrich von Both, 132230
RSV - NEW THERAPEUTIC HORIZONS BRING CLINICAL CHALLENGES
ESPID eLearning, Steve Cunningham, 132215
SEASONAL AND PANDEMIC INFLUENZA IN PAEDIATRIC INTENSIVE CARE UNITS IN ENGLAND AND WALES: RISK FACTORS FOR ADMISSION AND MORTALITY
ESPID eLearning, Pia Hardelid, 132216
DIAGNOSIS AND PATHOPHYSIOLOGY OF BIOFILM INFECTIONS IN CYSTIC FIBROSIS
ESPID eLearning, Niels Hoeiby, 132217
DEXAMETHASONE FOR PLEURAL INFECTION IN CHILDREN: A DOUBLE BLIND, RANDOMIZED, CLINICAL TRIAL OF EFFICACY AND SAFETY
ESPID eLearning, ALFREDO TAGARRO, 132218
NASOPHARYNGEAL BACTERIAL DENSITY IS INCREASED BY VIRAL RESPIRATORY INFECTIONS WHICH MAY FACILITATE TRANSMISSION
ESPID eLearning, Valtyr Thors, 132219
HIGHLIGHTS & LESSONS FROM THE FIRST 17 YEARS OF THE BRIGHTON COLLABORATION
ESPID eLearning, Jan Bonhoeffer, 132220
ENHANCING VACCINE SAFETY CAPACITY GLOBALLY: A LIFECYCLE PERSPECTIVE
ESPID eLearning, Robert Chen, 132221
NO ASSOCIATION OF THE TEN-VALENT PNEUMOCOCCAL CONJUGATE VACCINE (PCV10) WITH PREVIOUSLY SUGGESTED PCV SAFETY SIGNALS
ESPID eLearning, Arto A Palmu, 132222
INFLUENZA VACCINATION IN CHILDREN WITH CYSTIC FIBROSIS USING INTRANASAL LIVE ATTENUATED INFLUENZA VACCINE: EXPERIENCE FROM AN AUSTRIAN PAEDIATRIC HOSPITAL
ESPID eLearning, Sabine Renner, 132223
EXPLORING INCIDENCE RATES OF GUILLIAIN BARR
ESPID eLearning, Jozica Skufca, 132224
MEASUREMENT OF FEVER AFTER INFANT IMMUNISATIONS: COMPARISON OF INTERMITTENT AND 24 HOURS CONTINUOUS MONITORING
ESPID eLearning, Marta Valente Pinto, 132225
USING SMS TECHNOLOGY FOR REAL-TIME SURVEILLANCE OF ADVERSE EVENTS FOLLOWING IMMUNISATION
ESPID eLearning, Darren Westphal, 132226
THE RESURGENCE OF PERTUSSIS: FACTS, FICTION, MYTHS AND MISCONCEPTIONS?
ESPID eLearning, James Cherry, 132214
BILL MARSHALL LECTURE & AWARD: INTRODUCTION
ESPID eLearning, Adam Finn, 135835
ESCAPETB PROJECT -ENVIRONMENTAL SURVEILLANCE IN CANADA AND CAPE TOWN - IMPROVING OUR UNDERSTANDING OF AIRBORNE PATHOGEN EXPOSURE WITH A FOCUS ON TRANSMISSION OF ROD-SHAPED (MYCO-)BACTERIA)
ESPID eLearning, Vanden Driessche Koen, 132208
DISCOVERY OF IMMUNODOMINANT B CELL EPITOPES WITHIN SURFACE PNEUMOCOCCAL VIRULENCE PROTEINS IN PEDIATRIC PATIENTS WITH INVASIVE PNEUMOCOCCAL DISEASE
ESPID eLearning, Theano Lagousi, 132206
IMMUNOGENICITY OF REDUCED DOSE PRIMING SCHEDULES OF SEROGROUP C MENINGOCOCCAL CONJUGATE VACCINE FOLLOWED BY BOOSTER AT 12 MONTHS IN INFANTS: OPEN LABEL RANDOMISED CONTROLLED TRIAL
ESPID eLearning, David Pace, 132205
HOW DOES THE GUT-MICROBIOTA INFLUENCE THE ONSET AND NATURE OF JUVENILE IDIOPATHIC ARTHRITIS?
ESPID eLearning, Paula Sanchez, 132203
ZIKA VÍRUS AND GESTATION: FIRST CASES DETECTED IN SERGIPE
ESPID eLearning, Eitan Berezin, 132197
EARLY ANTIRETROVIRAL THERAPY PRESERVES THYMIC OUTPUT IN CHILDREN INFECTED WITH HUMAN IMMUNODEFICIENCY VIRUS: EVIDENCE FROM THE CHILDREN WITH HIV EARLY ANTIRETROVIRAL THERAPY (CHER) TRIAL
ESPID eLearning, Helen Payne, 132198
PROTECTING AGAINST THE CHANGELING DEMON AND THE TROLL OF TRANSPLANTATION
ESPID eLearning, Stanley Plotkin, 132199
USING BIOMARKERS TO GUIDE MANAGEMENT IN THE EMERGENCY DEPARTMENT
ESPID eLearning, Alain Gervaix, 132182
CLINICAL SIGNS AND POINT OF CARE TESTING IN FEBRILE CHILDREN
ESPID eLearning, Henriette Moll, 132183
PREVENTING EBOLA - THE RING VACCINATION STUDY
ESPID eLearning, Ana Maria Henao-Restrepo, 132187
NEUROLOGICAL AND AUTOIMMUNE COMPLICATIONS OF ZIKA VIRUS INFECTION
ESPID eLearning, Marco Safadi, 132188
A PRACTICAL GUIDE TO GETTING THE DOSE RIGHT
ESPID eLearning, Roger Brüggemann, 132189
PHARMACOMETRIC MODELS AND IN SILICO STUDIES
ESPID eLearning, Marc Pfister, 132192
POPULATION PHARMACOKINETICS AND PHARMACODYNAMICS OF TEICOPLANIN IN NEONATES
ESPID eLearning, Virginia Ramos Martin, 132193
IS IMMUNISING CHILDREN REALLY THE BEST WAY TO PROTECT THE ELDERLY AGAINST FLU?
ESPID eLearning, Marc Baguelin, 132194
UNIVERSAL CHILDHOOD VARICELLA VACCINE - MODELLING AND ETHICAL CONSTRUCTS
ESPID eLearning, Philippe Beutels, 132195

  • This eLearning portal is powered by MULTIEPORTAL
  • This eLearning portal is powered by: